Appendicitis and Hypertrophic cardiomyopathy

Summary:

Hypertrophic cardiomyopathy is found among people with Appendicitis, especially for people who are female, 50-59 old.

The study analyzes which people have Hypertrophic cardiomyopathy with Appendicitis. It is created by eHealthMe based on reports of 11 people who have Appendicitis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Appendicitis?

Appendicitis (inflammation of the appendix) is found to be associated with 833 drugs and 897 conditions by eHealthMe. Check the latest studies of Appendicitis.

What is Hypertrophic cardiomyopathy?

Hypertrophic cardiomyopathy (a condition in which the heart muscle becomes abnormally thick) is found to be associated with 264 drugs and 944 conditions by eHealthMe. Check the latest studies of Hypertrophic cardiomyopathy.

On Aug, 05, 2026

11 people who have Appendicitis and Hypertrophic Cardiomyopathy are studied.

Would you have Hypertrophic cardiomyopathy when you have Appendicitis?

Gender of people who have Appendicitis and experienced Hypertrophic Cardiomyopathy *:

female: 100 %
male: 0.0 %

Age of people who have Appendicitis and experienced Hypertrophic Cardiomyopathy *:

Common co-existing conditions for these people *:

Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure): 11 people, 100.00%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 10 people, 90.91%
Electroencephalogram Abnormal: 4 people, 36.36%
Anaesthesia: 3 people, 27.27%

Common drugs taken by these people *:

Valproic Acid: 11 people, 100.00%
Propofol: 11 people, 100.00%
Phenytoin: 11 people, 100.00%
Midazolam: 11 people, 100.00%
Levetiracetam: 11 people, 100.00%
Methylprednisolone: 9 people, 81.82%
Isoflurane: 8 people, 72.73%
Methylprednisolone Sodium Succinate: 6 people, 54.55%
Ketamine Hydrochloride: 6 people, 54.55%
Tegretol: 4 people, 36.36%

Common symptoms for these people *:

Abdominal Distension: 11 people, 100.00%
Systemic Inflammatory Response Syndrome (an inflammatory state affecting the whole body, frequently a response of the immune system to infection): 11 people, 100.00%
Necrosis Ischaemic (death of cell due to lack of blood supply): 11 people, 100.00%
Nausea And Vomiting: 11 people, 100.00%
Gastrointestinal Perforation (hole in the digestive tract): 11 people, 100.00%
Intra-Abdominal Pressure Increased: 11 people, 100.00%
Abscess (pus): 5 people, 45.45%
Enlarged Heart: 5 people, 45.45%
Hypotension (abnormally low blood pressure): 5 people, 45.45%
Intestinal Ischaemia (decreased supply of oxygenated blood to the intestines): 5 people, 45.45%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hypertrophic cardiomyopathy?

- Check whether Hypertrophic cardiomyopathy is associated with a drug or a condition

Related publications that referenced our studies

Kim DJ, Lee SC, Park GS, Kim GJ, Hwang WT, Lee CS, Lee MH, Hahn DH, Koh HC, "Amiodarone Induced Multiorgan Toxicity in a Patient of Hypertrophic Cardiomyopathy With Atrial Fibrillation", Journal of the Korean Geriatrics Society, 2013 Dec .
Kim DJ, Lee SC, Park GS, Kim GJ, Hwang WT, Lee CS, Lee MH, Hahn DH, Koh HC, "Amiodarone Induced Multiorgan Toxicity in a Patient of Hypertrophic Cardiomyopathy With Atrial Fibrillation", Journal of the Korean Geriatrics Society, 2013 Dec .

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hypertrophic cardiomyopathy and Appendicitis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.